Ionis Pharmaceuticals, Inc. ( IONS) - Stock Earnings
IONS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 5, 2026, midnight | — / — | — | — / — | — |
IONS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -128.6 million USD | 156.7 million USD |
| 2025Q4 | -229.0 million USD | 203.0 million USD |
| 2026Q1 | -92.5 million USD | 246.1 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
IONS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -366.3 million USD | 787.6 million USD |
| 2024 | -453.9 million USD | 705.1 million USD |
| 2025 | -381.0 million USD | 944.0 million USD |
| 2026 Est. | — | — |
IONS
Price: $56.55
52 week price:
Earnings Per Share: -2.01 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Ebitda: 9.5 millionMarket Capitalization: 13.5 billion